PVCMX
Price
$12.23
Change
-$0.01 (-0.08%)
Updated
Mar 10 closing price
Net Assets
248.23M
SSGSX
Price
$43.41
Change
-$0.88 (-1.99%)
Updated
Mar 10 closing price
Net Assets
6.08B
Ad is loading...

PVCMX vs SSGSX

Header iconPVCMX vs SSGSX Comparison
Open Charts PVCMX vs SSGSXBanner chart's image
Palm Valley Capital Investor
Price$12.23
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets248.23M
Victory Sycamore Small Company Opp A
Price$43.41
Change-$0.88 (-1.99%)
VolumeN/A
Net Assets6.08B
PVCMX vs SSGSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PVCMX vs. SSGSX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PVCMX is a StrongBuy and SSGSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 6.08B vs. PVCMX (248M). PVCMX pays higher dividends than SSGSX: PVCMX (3.68) vs SSGSX (0.49). PVCMX was incepted earlier than SSGSX: PVCMX (6 years) vs SSGSX (26 years). PVCMX (1.47) is less costly to investors than SSGSX (1.26). PVCMX is a more actively managed with annual turnover of: 55.00 vs. SSGSX (37.00). PVCMX (2500) and SSGSX (2500) have matching initial minimum investment requirements. PVCMX annual gain was more profitable for investors over the last year : 1.05 vs. SSGSX (-7.75). PVCMX return over 5 years is better than : 31.48 vs. SSGSX (16.91).
PVCMXSSGSXPVCMX / SSGSX
Total Expense Ratio1.261.26100%
Annual Report Gross Expense Ratio1.471.26117%
Fund Existence6 years26 years-
Gain YTD0.410-4.609-9%
Front LoadN/A6%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets248M6.08B4%
Annual Yield % from dividends3.680.49756%
Returns for 1 year1.05-7.75-14%
Returns for 3 years8.32-6.03-138%
Returns for 5 years31.4816.91186%
Returns for 10 yearsN/A18.80-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRDA10.770.35
+3.36%
Entrada Therapeutics
AMAT155.684.14
+2.73%
Applied Materials
ARQT14.720.22
+1.52%
Arcutis Biotherapeutics
KORE2.510.01
+0.40%
KORE Group Holdings
CMA58.30-0.16
-0.27%
Comerica